Skip to main content

Hemgenix 1 × 1013 genome copies/mL suspension for intravenous infusion Images

Generic Name: etranacogene dezaparvovec

This medication has been identified as Hemgenix 1 × 1013 genome copies/mL suspension for intravenous infusion. It is supplied by CSL Behring.

Hemgenix is used in the treatment of Hemophilia B and belongs to the drug class miscellaneous coagulation modifiers. Hemgenix 1 × 1013 genome copies/mL suspension for intravenous infusion is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Hemgenix 1 × 10<sup>13</sup> genome copies/mL suspension for intravenous infusion medicine

Hemgenix

Generic Name
etranacogene dezaparvovec
Strength
1 × 1013 genome copies/mL suspension for intravenous infusion
Availability
Prescription only
Drug Class
Miscellaneous coagulation modifiers
CSA Schedule
Not a controlled drug
Labeler / Supplier
CSL Behring
National Drug Code (NDC)

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.